REAL-WORLD EVIDENCE OF PREVALENCE OF CARDIOVASCULAR DISEASE AMONGST TREATED DIABETES POPULATION IN 2016

被引:0
|
作者
Khamis, Z. J. [1 ]
Merali, T. [1 ]
机构
[1] Drug Intelligence Inc, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PDB7
引用
收藏
页码:A163 / A163
页数:1
相关论文
共 50 条
  • [21] Real-World Evidence Demonstrating The Association Of SGLT2 Inhibitors With Reduced Cardiovascular Disease In Patients With Type 2 Diabetes
    Wang, Wendy
    Chen, Lin Y.
    Walker, Rob
    Chow, Lisa
    Norby, Faye L.
    Alonso, Alvaro
    Pankow, Jim S.
    Lutsey, Pamela L.
    CIRCULATION, 2022, 145
  • [22] Real-World Evidence of the Prevalence of Driver Mutations in Anorectal Melanoma
    Jutten, E.
    van Kempen, L. C. L. T.
    Diercks, G. F. H.
    van Leeuwen, B. L.
    Kruijff, S.
    Wevers, K. P.
    MOLECULAR DIAGNOSIS & THERAPY, 2025, 29 (02) : 229 - 238
  • [23] Prevalence of cardiovascular disease and treatment pattern in patients with type 2 diabetes in a real world setting
    Weng, W.
    Tian, Y.
    Kong, X.
    Ganguly, R.
    Hersloev, M.
    Brett, J.
    Hobbs, T.
    DIABETOLOGIA, 2018, 61 : S136 - S136
  • [24] Incidence of Hypoglycemia Events in a Large, Real-World Diabetes Population
    Bollyky, Jennifer
    Lu, Wei
    Schneider, Jennifer
    DIABETES, 2018, 67
  • [25] Real-world evidence on levodopa dose escalation in patients with Parkinson's disease treated with istradefylline
    Hattori, Nobutaka
    Kabata, Daijiro
    Asada, Shinji
    Kanda, Tomoyuki
    Nomura, Takanobu
    Shintani, Ayumi
    Mori, Akihisa
    PLOS ONE, 2023, 18 (12):
  • [26] Prevalence and Risk Factors of Cardiovascular Disease in Rheumatoid Arthritis Patients: A Comparative Analysis of Real-World Data
    Tekeoglu, Senem
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 5859 - 5868
  • [27] Cardiovascular Event Rates in Statin-Treated Korean Patients with Cardiovascular Disease: Estimates from a Real-World Population Using Electronic Medical Record Data
    Kwon, Osung
    Na, Wonjun
    Hur, Jaehee
    Kim, Ju Hyeon
    Jun, Tae Joon
    Kang, Hee Jun
    Lee, Hojoon
    Kim, Young-Hak
    CARDIOVASCULAR DRUGS AND THERAPY, 2023, 37 (01) : 129 - 140
  • [28] Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective
    Chen, Jie
    Gruber, Susan
    Lee, Hana
    Chu, Haitao
    Lee, Shiowjen
    Tian, Haijun
    Wang, Yan
    He, Weili
    Jemielita, Thomas
    Song, Yang
    Tamura, Roy
    Tian, Lu
    Zhao, Yihua
    Chen, Yong
    van Der Laan, Mark
    Nie, Lei
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (04) : 946 - 960
  • [29] Cardiovascular Event Rates in Statin-Treated Korean Patients with Cardiovascular Disease: Estimates from a Real-World Population Using Electronic Medical Record Data
    Osung Kwon
    Wonjun Na
    Jaehee Hur
    Ju Hyeon Kim
    Tae Joon Jun
    Hee Jun Kang
    Hojoon Lee
    Young-Hak Kim
    Cardiovascular Drugs and Therapy, 2023, 37 : 129 - 140
  • [30] Machine Learning Methods in Real-World Studies of Cardiovascular Disease
    Zhou, Jiawei
    You, Dongfang
    Bai, Jianling
    Chen, Xin
    Wu, Yaqian
    Wang, Zhongtian
    Tang, Yingdan
    Zhao, Yang
    Feng, Guoshuang
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2022, 7 (01)